ALPCO

Company Snapshot

Founded: 1991
Entity Type: Private
Region: U.S.
Headquarter: New Hampshire, U.S.
Key Geographics: North America
Corporate Address: 26-g Keewaydin Drive, Salem, New Hampshire 03079, U.S. Tel.: +1-608-898-6854 Web.: www.alpco.com

Company Overview

ALPCO was founded in 1991 as an importer and distributor of immunoassay-based products for the North American life sciences markets and has since grown into a premier channel representing over 60 collaborating partners from around the globe. It began as a provider of immunoassays. Over recent years, it has expanded its offerings to include HPLC and LC/MS-MS reagents, purified antibodies, recombinant proteins, flow cytometry reagents, and chemiluminescent assays

ALPCO In Reports

3D Cell Cultures: Technologies and Global Markets

BCC Research Market Analyst says global market for 3D cell culture is estimated to increase from $4.6 billion in 2023 to reach $14.8 billion by 2028 at a CAGR of 26.5% from 2023 through 2028.

3D Cell Cultures: Technologies and Global Markets

BCC Research Market Report says global market for cell culture should grow from $10.3 billion in 2020 to $14.8 billion by 2025, at a compound annual growth rate of 7.5%.

Flow Cytometry: Products, Technologies and Global Markets

The global market for flow cytometry should grow from $4.6 billion in 2018 to $7.3 billion in 2023, growing at a compound annual growth rate of 9.7% from 2018 through 2023.

Company's Business Segments

  • Immuno and Molecular Diagnostics : This segment includes Developing, Distributing of Molecular and Immunodiagnostic products focused on Infectious and Gastroenterological Diseases.

Applications/End User Industries

  • Immunoassay
  • Chemiluminescence
  • Immunoturbidimetric
  • Molecular Diagnostics
  • Immunodiagnostics
  • Life Sciences
  • Gastroenterology
  • Infectious Diseases
  • Diabetes
  • Obesity
  • Endocrinology
  • Immunology
AI Sentiment